Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peanut OIT for Desensitization vs Tolerance (POISED)
NCT02103270Phase 2Completed
- Sponsor
- Stanford University
- Start
- Apr 2014
- Primary completion
- Jul 2018
- Modality
- Recombinant Proteins and Enzymes, Allergy Immunotherapy
- Countries
- 1
01
Overview
A Phase 2 trial of peanut protein in peanut allergy, sponsored by Stanford University. Started Apr 2014; status: completed.
02
Drugs
peanut protein
03
Conditions
peanut allergy
Beyond the preview
Go deeper on NCT02103270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02103270.